Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Crisis management in pharmaceuticals: evidence from Greece

Crisis management in pharmaceuticals: evidence from Greece Purpose – The purpose of this paper is to explore the practice, prevention, and problems pharmaceutical companies face with respect to crisis management (CM). The pharmaceutical sector is considered to be the most crisis prone of all industries. Design/methodology/approach – The study is exploratory in nature and data were collected by carrying out semi‐structured in‐depth interviews with key managers in 16 pharmaceutical companies. The open‐ended questions were content analyzed. Findings – Respondents identified product recall as the major reason for business crisis in pharmaceutical companies. Also, the results revealed that the large‐sized companies had CM departments or had collaborated with consulting firms. Research limitations/implications – This is a limited exploratory study restricted to one country. However, Greece's pharmaceutical expenditure is above the average in OECD countries. Suggestions are presented for future studies and especially for generalization of the findings. Practical implications – Today's business environment requires a robust, enterprise‐wide plan to deal with crises, especially in pharmaceutical companies where a “mistake” can lead to civilian casualties. Originality/value – This study offers empirical findings from pharmaceutical companies, where studies are limited and broadly confirms the findings and conclusions of earlier studies in other industries in the international context. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Pharmaceutical and Healthcare Marketing Emerald Publishing

Crisis management in pharmaceuticals: evidence from Greece

Download PDF
15 pages

Loading next page...
 
/lp/emerald-publishing/crisis-management-in-pharmaceuticals-evidence-from-greece-ZLj0P7kliG

References (49)

Publisher
Emerald Publishing
Copyright
Copyright © 2008 Emerald Group Publishing Limited. All rights reserved.
ISSN
1750-6123
DOI
10.1108/17506120810887899
Publisher site
See Article on Publisher Site

Abstract

Purpose – The purpose of this paper is to explore the practice, prevention, and problems pharmaceutical companies face with respect to crisis management (CM). The pharmaceutical sector is considered to be the most crisis prone of all industries. Design/methodology/approach – The study is exploratory in nature and data were collected by carrying out semi‐structured in‐depth interviews with key managers in 16 pharmaceutical companies. The open‐ended questions were content analyzed. Findings – Respondents identified product recall as the major reason for business crisis in pharmaceutical companies. Also, the results revealed that the large‐sized companies had CM departments or had collaborated with consulting firms. Research limitations/implications – This is a limited exploratory study restricted to one country. However, Greece's pharmaceutical expenditure is above the average in OECD countries. Suggestions are presented for future studies and especially for generalization of the findings. Practical implications – Today's business environment requires a robust, enterprise‐wide plan to deal with crises, especially in pharmaceutical companies where a “mistake” can lead to civilian casualties. Originality/value – This study offers empirical findings from pharmaceutical companies, where studies are limited and broadly confirms the findings and conclusions of earlier studies in other industries in the international context.

Journal

International Journal of Pharmaceutical and Healthcare Marketing – Emerald Publishing

Published: Jun 27, 2008

Keywords: Pharmaceuticals industry; Marketing; Quality control; Product reliability; Greece

There are no references for this article.